Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration
Cholangiocarcinomas (CHOLs), hepatobiliary malignancies, are characterized by high genetic heterogeneity, a rich tumor microenvironment, therapeutic resistance, difficulty diagnosing, and poor prognoses. Current knowledge of genetic alterations and known molecular markers for CHOL is insufficient, n...
Guardado en:
Autores principales: | Bashir Lawal, Yu-Cheng Kuo, Sung-Ling Tang, Feng-Cheng Liu, Alexander T. H. Wu, Hung-Yun Lin, Hsu-Shan Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c50411c8735f464bb34f797892f3c59d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antigua palabra narrativa indígena Ch'ol /
por: Morales Bermúdez, Jesús
Publicado: (1999) -
Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
por: Anthony Vignone, et al.
Publicado: (2021) -
Vascular Resection in Perihilar Cholangiocarcinoma
por: Alejandro Serrablo, et al.
Publicado: (2021) -
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
por: He C, et al.
Publicado: (2021) -
MANAGING SYMPTOM CLUSTER AMONG PATIENTS WITH CHOLANGIOCARCINOMA: A CALL FOR NURSES
por: Surachai Maninet, et al.
Publicado: (2018)